- 66Reports naming them
- 2Categories
- 33Regions & countries
- See reportsGrowth in full reports
Where they show up
Geographies
- Africa 2
- APAC 2
Australia 2
Brazil 2
Canada 2
China 2
Ecuador 2
Egypt 2- Europe 2
France 2
Germany 2- Global 2
Hong Kong 2
India 2
Italy 2
Japan 2
Kenya 2- Latin America 2
Malaysia 2
Mexico 2- Middle East 2
New Zealand 2- North America 2
Philippines 2
Russia 2
Saudi Arabia 2
Singapore 2
South Africa 2
Spain 2
Thailand 2
UAE 2
UK 2
US 2
23andMe's markets
| Market | Category | World size | Growth |
|---|---|---|---|
| Direct-to-Consumer Genetic Testing | Pharmaceuticals | In full report | In full report |
| Polygenic Risk Scores | Medical Devices | In full report | In full report |
Companies they compete with most
Named as key players in the same markets as 23andMe (number of shared markets).
Color Health2 shared markets
Allelica1 shared market
Ancestry1 shared market
Genomics plc1 shared market
MyHeritage1 shared market
Myriad Genetics, Inc.1 shared market
Nebula Genomics, Inc.1 shared market
Myriad Genetics, Inc.1 shared market
Nebula Genomics, Inc.1 shared market
Recent reports naming 23andMe
- Pharmaceuticals South Africa Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals US Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals Thailand Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals Singapore Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals Saudi Arabia Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals Russia Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals Philippines Direct-to-Consumer Genetic Testing Market Analysis
- Pharmaceuticals New Zealand Direct-to-Consumer Genetic Testing Market Analysis